Arterial stiffness evaluation in HIV-positive patients: A multicenter matched control study

American Journal of Roentgenology

Volumn 197, Issue 5, 2011, Pages 1258-1262

  Ferraioli, Giovanna ^a   Tinelli, Carmine ^b   Maggi, Paolo ^c   Gervasoni, Cristina ^d   Grima, Pierfrancesco ^e   Viskovic, Klaudija ^f   Carerj, Scipione ^g   Filice, Gaetano ^a   Filice, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Infectious Diseases Department   (Italy)

^f Croatia   (Croatia)

^g UNIVERSITY OF MESSINA   (Italy)

Author keywords

Arterial compliance; Arterial stiffness; Atherosclerosis; HIV infection; Matched studies; Ultrasound

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; RISK FACTOR; SEX;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAROTID ARTERIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 80054891451     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6712     Document Type: Article

References (22)

1. Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF. Cardiovascular disease in HIV infection. Am Heart J 2006; 151:1147-1155 (Pubitemid 44172869)
2. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001; 104:257-262 (Pubitemid 32666944)
3. Ho JE, Hsue PY. Cardiovascular manifestations in HIV infection. Heart 2009; 95:1193-1202
4. Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009; 23:1059-1067
5. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis: the Rotterdam study. Arterioscler Thromb 1994; 14:1885-1891
6. Verhamme P, Kerkhof F, Buysschaert I, Rietzschel E, de Groot E. Carotid intima-media thickness: more than a research tool? Acta Cardiol 2010; 65:59-66
7. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265 (Pubitemid 34084631)
8. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-Invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605 (Pubitemid 44627304)
9. Luc M, Polonsky T, Lammertin G, Spencer K. Automated border detection for assessing the mechanical properties of the carotid arteries: comparison with carotid intima-media thickness. J Am Soc Echocardiogr 2010; 23:567-572
10. Dijk JM, Algra A, van der Graaf Y, Grobbee DE, Bots ML; SMART study group. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease: the SMART study. Eur Heart J 2005; 26:1213-1220 (Pubitemid 40863128)
11. Rakebrandt F, Palombo C, Swampillai J, et al. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound: rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol 2009; 35:266-277
12. Ross AC, Rizk N, O'Riordan MA, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis 2009; 49:1119-1127
13. Dubé MP, Sattler FR. Inflammation and complications of HIV disease. J Infect Dis 2010; 201:1783-1785
14. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795
15. Grunfeld C, Delaney JA, Wanke C, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009; 23:1841-1849
16. + T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008; 22:1615-1624
17. Currier JS, Kendall MA, Henry WK, et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 2007; 21:1137-1145 (Pubitemid 46763284)
18. Johnsen S, Dolan SE, Fitch KV, et al. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 2006; 91:4916-4924 (Pubitemid 44917327)
19. Benetos A, Waeber B, Izzo J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002; 15:1101-1108 (Pubitemid 35397546)
20. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15:426-444 (Pubitemid 34478483)
21. Kuller LH, Tracy R, Belloso W, et al. INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203
22. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM 2002; 95:67-74 (Pubitemid 34187779)